During COVID-19 Vaccine Race Biotech Stocks To Be Watched
The corona condition is getting worse day by day in the world; lockdown continues in many countries throughout the globe, and the virus has contaminated more than 2 million people leaving nearly 120,000 people dead. Currently, a lot of organizations are concerned in the improvement of a coronavirus vaccine. The pharmaceutical companies proceed the race to be the first to license a COVID-19 vaccine and some of them have already made excellent progress, while others are at the very beginning of the race. Every organization is making use of various technology platforms to create experimental vaccines.
Here are the 6 essential Biotech shares that we think the investors have to watch now. Gulf Brokerssee, however, massive volatility in these shares as traders will proceed to speculate as to whether these companies will, as for the vaccine, come out on top.
Gilead Sciences Inc. (NASDAQ: GILD)
Johnson & Johnson, Inc. (NYSE: JNJ)
GlaxoSmithKline plc. (LON: GSK) and Sanofi (EPA: SAN)
Pfizer, Inc. (NYSE: PFE)
Moderna, Inc. (NASDAQ: MRNA)
Inovio Pharmaceuticals (NASDAQ: INO)
Medical companies globally are tirelessly working to develop vaccines and cure for COVID-19. We expect a similarly upside strength in the biotech and pharmaceutical sectors throughout this crisis. But as we know, these experimental drugs are in the early stages and there is no assurance that these drugs will reap the FDA approval. The good news is that a number of biotech companies have already obtained the aid of government funding.
Trading is risky and your whole investment may be at risk. TC’s available at https://gulfbrokers.com/